trending Market Intelligence /marketintelligence/en/news-insights/trending/233bsuk-snmgle93bqbqcg2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

Zafgen closes $69M common stock offering


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Zafgen closes $69M common stock offering

Zafgen Inc., a health care delivery and management company, closed its underwritten public offering of 9.2 million of its common shares at $7.50 apiece for gross proceeds of $69.0 million.

The shares sold included 1.2 million common shares sold pursuant to the full exercise of the underwriters' overallotment option.

All of the shares in the offering were sold by the Boston-based biotechnology company.

Cowen and Co. LLC and Piper Jaffray & Co. served as joint book-running managers and JMP Securities LLC and Wedbush Securities Inc. served as co-lead managers for the offering.

Zafgen develops therapies to treat metabolically related disorders.